↓ Skip to main content

Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry

Overview of attention for article published in Frontiers in Neurology, June 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
17 X users

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
58 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry
Published in
Frontiers in Neurology, June 2021
DOI 10.3389/fneur.2021.693017
Pubmed ID
Authors

Cecilia Smith Simonsen, Heidi Øyen Flemmen, Line Broch, Cathrine Brunborg, Pål Berg-Hansen, Stine Marit Moen, Elisabeth Gulowsen Celius

X Demographics

X Demographics

The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 58 100%

Demographic breakdown

Readers by professional status Count As %
Other 8 14%
Student > Ph. D. Student 8 14%
Researcher 5 9%
Student > Bachelor 3 5%
Professor > Associate Professor 3 5%
Other 5 9%
Unknown 26 45%
Readers by discipline Count As %
Medicine and Dentistry 15 26%
Neuroscience 10 17%
Psychology 2 3%
Agricultural and Biological Sciences 1 2%
Materials Science 1 2%
Other 0 0%
Unknown 29 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 August 2023.
All research outputs
#3,110,511
of 26,103,952 outputs
Outputs from Frontiers in Neurology
#1,731
of 14,848 outputs
Outputs of similar age
#73,091
of 462,056 outputs
Outputs of similar age from Frontiers in Neurology
#60
of 630 outputs
Altmetric has tracked 26,103,952 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 14,848 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 462,056 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 630 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.